VitaNova Life Sciences Corporation Proceeds from Issuance of Private Placement
VitaNova Life Sciences Corporation (VNOV) reported Proceeds from Issuance of Private Placement of $0 for the 12-month period ending 2025-04-30, per its 10-K filed 2025-07-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-07-24
- VitaNova Life Sciences Corporation proceeds from issuance of private placement for the quarter ending 2025-04-30 was $0.00.
- VitaNova Life Sciences Corporation proceeds from issuance of private placement for the quarter ending 2024-04-30 was $0.00.
- VitaNova Life Sciences Corporation proceeds from issuance of private placement for the quarter ending 2023-04-30 was $0.00.
- VitaNova Life Sciences Corporation proceeds from issuance of private placement for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- VitaNova Life Sciences Corporation proceeds from issuance of private placement for fiscal 2024 was $957.05K.
- VitaNova Life Sciences Corporation proceeds from issuance of private placement for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|
| 2025-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $0.00 10-K · filed 2025-07-24 | |
| 2025-01-31 | $0.00 10-Q · filed 2025-03-17 | ||
| 2024-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $957.05K 10-K · filed 2025-07-24 | |
| 2024-01-31 | $957.05K 10-Q · filed 2025-03-17 | ||
| 2023-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-29 | $0.00 10-K · filed 2024-07-29 | |
| 2023-01-31 | $0.00 10-Q · filed 2024-03-11 |